BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27997987)

  • 1. Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Savale L; Sattler C; Coilly A; Conti F; Renard S; Francoz C; Bouvaist H; Feray C; Borentain P; Jaïs X; Montani D; Parent F; O'Connell C; Hervé P; Humbert M; Simonneau G; Samuel D; Calmus Y; Duvoux C; Durand F; Duclos-Vallée JC; Sitbon O
    Hepatology; 2017 May; 65(5):1683-1692. PubMed ID: 27997987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
    Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW
    Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
    Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
    Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
    DuBrock HM; Del Valle KT; Krowka MJ
    Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portopulmonary hypertension.
    Krowka MJ
    Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension.
    Legros L; Chabanne C; Camus C; Fournet M; Houssel-Debry P; Latournerie M; Jezequel C; Rayar M; Boudjema K; Guyader D; Bardou-Jacquet E
    Dig Liver Dis; 2017 Mar; 49(3):301-307. PubMed ID: 27840058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
    Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
    Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portopulmonary hypertension in the current era of pulmonary hypertension management.
    Savale L; Guimas M; Ebstein N; Fertin M; Jevnikar M; Renard S; Horeau-Langlard D; Tromeur C; Chabanne C; Prevot G; Chaouat A; Moceri P; Artaud-Macari É; Degano B; Tresorier R; Boissin C; Bouvaist H; Simon AC; Riou M; Favrolt N; Palat S; Bourlier D; Magro P; Cottin V; Bergot E; Lamblin N; Jaïs X; Coilly A; Durand F; Francoz C; Conti F; Hervé P; Simonneau G; Montani D; Duclos-Vallée JC; Samuel D; Humbert M; De Groote P; Sitbon O
    J Hepatol; 2020 Jul; 73(1):130-139. PubMed ID: 32145258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
    Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
    J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portopulmonary hypertension: survival and prognostic factors.
    Le Pavec J; Souza R; Herve P; Lebrec D; Savale L; Tcherakian C; Jaïs X; Yaïci A; Humbert M; Simonneau G; Sitbon O
    Am J Respir Crit Care Med; 2008 Sep; 178(6):637-43. PubMed ID: 18617641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portopulmonary hypertension: Results from a 10-year screening algorithm.
    Krowka MJ; Swanson KL; Frantz RP; McGoon MD; Wiesner RH
    Hepatology; 2006 Dec; 44(6):1502-10. PubMed ID: 17133488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
    DuBrock HM
    Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portopulmonary hypertension: an update.
    Safdar Z; Bartolome S; Sussman N
    Liver Transpl; 2012 Aug; 18(8):881-91. PubMed ID: 22674534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension.
    Cartin-Ceba R; Burger C; Swanson K; Vargas H; Aqel B; Keaveny AP; Heimbach J; Taner T; Nyberg S; Rosen C; Cajigas H; DuBrock H; Krowka MJ
    Transplantation; 2021 Oct; 105(10):2283-2290. PubMed ID: 33065725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    DeMartino ES; Cartin-Ceba R; Findlay JY; Heimbach JK; Krowka MJ
    Transplantation; 2017 Jan; 101(1):101-106. PubMed ID: 28009757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.
    Jose A; Shah SA; Anwar N; Jones CR; Sherman KE; Elwing JM
    Liver Transpl; 2021 Dec; 27(12):1811-1823. PubMed ID: 33964116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Reymond M; Barbier L; Salame E; Besh C; Dumortier J; Pageaux GP; Bureau C; Dharancy S; Vanlemmens C; Abergel A; Woehl Jaegle ML; Magro P; Patat F; Laurent E; Perarnau JM
    Transplantation; 2018 Apr; 102(4):616-622. PubMed ID: 29077657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg.
    DuBrock HM; Runo JR; Sadd CJ; Burger CD; Cartin-Ceba R; Rosen CB; Taner T; Nyberg SL; Heimbach JK; Findlay JY; Krowka MJ
    Transplant Direct; 2020 Dec; 6(12):e630. PubMed ID: 33204828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.